Insider Trading & Ownership - Abingworth Bioventures VII LP

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Abingworth Bioventures VII LP
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-08
Purchase
2024-02-12
6:23 pm
Jasper Therapeutics Inc.JSPRCarlyle Group Inc.
Carlyle Holdings I GP Inc.
Carlyle Holdings I GP Sub L.L.C.
Carlyle Holdings I L.P.
CG Subsidiary Holdings L.L.C.
TC Group LLC
Carlyle Investment Management LLC
Carlyle Genesis UK LLC
Abingworth LLP
Abingworth Bioventures VII LP
Former 10% Owner
190,000$12.95$2,460,5001,066,189
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-09-28
Conversion
2023-10-02
7:54 pm
N/A
N/A
SOLENO THERAPEUTICS INCSLNOCarlyle Group Inc.
Carlyle Holdings I GP Inc.
Carlyle Holdings I GP Sub L.L.C.
Carlyle Holdings I L.P.
CG Subsidiary Holdings L.L.C.
TC Group LLC
Carlyle Investment Management LLC
Carlyle Genesis UK LLC
Abingworth LLP
Abingworth Bioventures VII LP
10% Owner
1,092,056$02,293,562
(Indirect)
View
2023-09-28
Conversion
2023-10-02
7:54 pm
N/A
N/A
SOLENO THERAPEUTICS INCSLNOCarlyle Group Inc.
Carlyle Holdings I GP Inc.
Carlyle Holdings I GP Sub L.L.C.
Carlyle Holdings I L.P.
CG Subsidiary Holdings L.L.C.
TC Group LLC
Carlyle Investment Management LLC
Carlyle Genesis UK LLC
Abingworth LLP
Abingworth Bioventures VII LP
10% Owner
1,092,056$1.752,293,562
(Indirect)
View